Nivolumab

299,00 

Therapeutic PD-1-antibody from the original Opdivo commercial drug targeting the PD-1-antigen, also referred to as Opdivo antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Storage [°C] Original therapeutic expiry date [see Note 1] CoA [see Note 2] PriceQuantityTotal
aliquot 102002AAQ3795-80°02/2018no 299,00 
-
+
299,00 
spinner
aliquot 102002AAN6970-80°08/2018no 299,00 
-
+
299,00 
spinner
aliquot 102002AAP6351-80°10/2018no 299,00 
-
+
299,00 
spinner
aliquot 102002AAW0883-80°01/2019no 299,00 
-
+
299,00 
spinner
aliquot 102002AAU3964-80°05/2019no 299,00 
-
+
299,00 
spinner
aliquot 102002AAX07422-8°/-80°11/2020no 299,00 
-
+
299,00 
spinner
aliquot 102002AAY27642-8°/-80°02/2021no 299,00 
-
+
299,00 
spinner
aliquot 102002AAW64092-8°/-80°09/2020no 299,00 
-
+
299,00 
spinner

Back to main shop Category: SKU: N/A

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Nivolumab

Antigen

PD-1

Product Concentration [mg/mL]

1, 10

Volume per Vial [µL]

100, 200

Quantity per vial [mg]

0, 0,1, 2

Batch Number

NOT APPLICABLE, AAN6970, AAP6351, AAU3964, AAW0883, AAW6409, AAY2764, -, AAQ3795, AAX0742

Storage [°C]

-, -80°, 2-8°/-80°

Original therapeutic expiry date [see Note 1]

02/2018, 11/2020, -, 01/2019, 02/2021, 05/2019, 08/2018, 09/2020, 10/2018, NOT APPLICABLE

CoA [see Note 2]

no

You may also like…